PRKCSH

protein kinase C substrate 80K-H, the group of MRH domain containing |EF-hand domain containing

Basic information

Region (hg38): 19:11435284-11450968

Previous symbols: [ "G19P1", "PCLD", "PLD1" ]

Links

ENSG00000130175NCBI:5589OMIM:177060HGNC:9411Uniprot:P14314AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • polycystic liver disease 1 (Strong), mode of inheritance: AD
  • polycystic liver disease 1 (Strong), mode of inheritance: AD
  • polycystic liver disease 1 (Definitive), mode of inheritance: AD
  • polycystic liver disease 1 (Supportive), mode of inheritance: AD
  • polycystic liver disease 1 (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Polycystic liver disease 1 with or without kidney cystsADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingGastrointestinal; Renal11047756; 12577059; 12529853; 16835903; 20095989; 22415584
Though some individuals may require treatment, it is unclear if early (genetic) diagnosis would be beneficial; Liver transplantion has been described

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PRKCSH gene.

  • not provided (8 variants)
  • Polycystic liver disease 1 (5 variants)
  • Autosomal dominant polycystic liver disease (1 variants)
  • PRKCSH-related disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRKCSH gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
12
clinvar
56
clinvar
4
clinvar
72
missense
123
clinvar
14
clinvar
1
clinvar
138
nonsense
3
clinvar
2
clinvar
5
start loss
0
frameshift
6
clinvar
3
clinvar
1
clinvar
10
inframe indel
20
clinvar
4
clinvar
2
clinvar
26
splice donor/acceptor (+/-2bp)
3
clinvar
6
clinvar
3
clinvar
12
splice region
9
11
4
24
non coding
10
clinvar
49
clinvar
27
clinvar
86
Total 12 11 169 123 34

Highest pathogenic variant AF is 0.0000328

Variants in PRKCSH

This is a list of pathogenic ClinVar variants found in the PRKCSH region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-11435448-G-A Polycystic liver disease 1 Benign (Jun 14, 2016)328161
19-11435484-CCTCT-C Polycystic liver disease 1 Likely benign (Jun 14, 2016)328162
19-11435591-G-A Polycystic liver disease 1 Uncertain significance (Jun 14, 2016)328163
19-11435616-G-A Polycystic liver disease 1 Uncertain significance (Jun 14, 2016)328164
19-11435641-G-A Polycystic liver disease 1 Likely benign (Jun 14, 2016)328165
19-11435654-C-T Polycystic liver disease 1 Benign (Jan 12, 2018)328166
19-11435665-C-G Polycystic liver disease 1 Benign (Jan 13, 2018)328167
19-11435679-T-C Polycystic liver disease 1 Uncertain significance (Jan 12, 2018)328168
19-11435744-T-C Primary ciliary dyskinesia 30 • ODAD3-related disorder Benign (Mar 09, 2022)1224193
19-11435762-G-T Primary ciliary dyskinesia 30 Uncertain significance (Apr 10, 2024)3766554
19-11435780-G-A ODAD3-related disorder Likely benign (Dec 29, 2023)3040071
19-11436039-A-C Polycystic liver disease 1 Uncertain significance (Mar 04, 2022)631808
19-11436129-G-C Likely benign (Oct 08, 2021)1652006
19-11436128-C-CGCT Uncertain significance (Jan 02, 2024)2167568
19-11436132-G-A Likely benign (Jan 30, 2023)2994473
19-11436139-C-A Polycystic liver disease 1 Uncertain significance (Aug 07, 2022)890780
19-11436152-G-A Polycystic liver disease 1 Uncertain significance (Mar 27, 2024)3583408
19-11436153-C-T Likely benign (Dec 03, 2024)2906750
19-11436154-T-C Polycystic liver disease 1 Benign/Likely benign (Jun 24, 2024)890781
19-11436155-G-C Inborn genetic diseases Conflicting classifications of pathogenicity (Jan 31, 2023)1529457
19-11436169-A-C Uncertain significance (Mar 09, 2024)3643869
19-11436177-C-T Polycystic liver disease 1 Likely benign (Nov 10, 2021)754953
19-11436184-G-C Inborn genetic diseases Uncertain significance (Apr 12, 2022)2392941
19-11436188-C-T Inborn genetic diseases Uncertain significance (Jan 30, 2024)3218807
19-11436192-C-CACCAGTGA Autosomal dominant polycystic liver disease Likely pathogenic (Sep 01, 2021)1255538

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PRKCSHprotein_codingprotein_codingENST00000252455 1615675
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.01e-70.9971257010471257480.000187
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5322863120.9150.00002133448
Missense in Polyphen91116.170.783361278
Synonymous-2.641781381.290.0000114964
Loss of Function2.641733.50.5080.00000169389

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002190.000210
Ashkenazi Jewish0.000.00
East Asian0.0001090.000109
Finnish0.0007540.000739
European (Non-Finnish)0.0001470.000141
Middle Eastern0.0001090.000109
South Asian0.0001970.000196
Other0.0003290.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Regulatory subunit of glucosidase II that cleaves sequentially the 2 innermost alpha-1,3-linked glucose residues from the Glc(2)Man(9)GlcNAc(2) oligosaccharide precursor of immature glycoproteins (PubMed:10929008). Required for efficient PKD1/Polycystin-1 biogenesis and trafficking to the plasma membrane of the primary cilia (By similarity). {ECO:0000250|UniProtKB:O08795, ECO:0000269|PubMed:10929008}.;
Disease
DISEASE: Polycystic liver disease 1 with or without kidney cysts (PCLD1) [MIM:174050]: An autosomal dominant hepatobiliary disease characterized by overgrowth of biliary epithelium and supportive connective tissue, resulting in multiple liver cysts. A subset of patients may develop kidney cysts that usually do not result in clinically significant renal disease. {ECO:0000269|PubMed:12529853, ECO:0000269|PubMed:12577059, ECO:0000269|PubMed:28375157}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Protein processing in endoplasmic reticulum - Homo sapiens (human);Post-translational protein phosphorylation;Calnexin/calreticulin cycle;Post-translational protein modification;Metabolism of proteins;Innate Immune System;Immune System;Fibroblast growth factor-1;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Asparagine N-linked glycosylation;Advanced glycosylation endproduct receptor signaling;N-glycan trimming in the ER and Calnexin/Calreticulin cycle (Consensus)

Recessive Scores

pRec
0.138

Intolerance Scores

loftool
0.445
rvis_EVS
-0.89
rvis_percentile_EVS
10.46

Haploinsufficiency Scores

pHI
0.165
hipred
N
hipred_score
0.414
ghis
0.581

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.927

Gene Damage Prediction

AllRecessiveDominant
MendelianHighMediumHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Prkcsh
Phenotype
homeostasis/metabolism phenotype; cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); renal/urinary system phenotype; liver/biliary system phenotype;

Zebrafish Information Network

Gene name
prkcsh
Affected structure
post-vent region
Phenotype tag
abnormal
Phenotype quality
kinked

Gene ontology

Biological process
N-glycan processing;intracellular signal transduction;post-translational protein modification;cellular protein metabolic process
Cellular component
endoplasmic reticulum;endoplasmic reticulum lumen;glucosidase II complex;intracellular membrane-bounded organelle
Molecular function
protein kinase C binding;calcium ion binding;protein binding;ion channel binding;phosphoprotein binding